Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).
In large multi-site trials, a feasibility or pilot study can be crucial to test the functionality of all aspects of conducting the study prior to the initiation of the formal study. A feasibility trial was conducted for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Project, a multi-site, prospective, sequentially randomized, clinical trial of outpatients with nonpsychotic major depressive disorder. From 14 December 2000 to 8 June 2001, 42 patients were screened for enrollment into the STAR*D Feasibility Trial. Twenty-four patients who were eligible and consented to participate were treated with citalopram for up to 12 weeks. During the course of this trial, issues were raised that resulted in modifications to the study procedures. Modifications made as a result of this trial affected four domains: (1) communication, (2) patient and provider burden, (3) data collection forms, and (4) recruitment and retention of subjects. This paper describes what was learned during the STAR*D Feasibility Trial so researchers planning to conduct similar trials can learn the practical issues related to conducting such a research project. While the information gathered was useful, it did delay the initiation of the formal trial. We view this cost as an investment in the development of overall study procedures that should lead to a stronger study.
Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. wisniew@edc.pitt.edu
Stephen R
SR
Wisniewski
Diane
D
Stegman
Madhukar
M
Trivedi
Mustafa M
MM
Husain
Heather
H
Eng
Kathy
K
Shores-Wilson
James
J
Luther
Melanie M
MM
Biggs
Diane
D
Burroughs
A Louise
AL
Ritz
Maurizio
M
Fava
Frederic
F
Quitkin
A John
AJ
Rush
D002986:Clinical Trials as Topic / Q000379:methods*; D003142:Communication; D000529:Complementary Therapies; D003625:Data Collection; D003866:Depressive Disorder / Q000628:therapy*; D023381:Endpoint Determination; D005240:Feasibility Studies; D006801:Humans; D015337:Multicenter Studies as Topic; D010352:Patient Dropouts; D018579:Patient Selection; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012107:Research Design; D018401:Sample Size